Optimizing Therapy for Patients with Advanced Renal Cell Carcinoma - Episode 5

Treatment Strategies for Non-Clear Cell Renal Cell Carcinoma

, , , , ,

Expert panelists review the management of non-clear cell histology in renal cell carcinoma, exploring treatment options, clinical trials, and the potential role of immune checkpoint inhibitors.

EP. 1: Overview on Advanced RCC: Epidemiology, Presentation, and Risk Stratification
EP. 2: Frontline Therapy for Advanced Renal Cell Carcinoma: Patient Scenario Discussion
EP. 3: Imaging and Staging Considerations in Renal Cell Carcinoma
EP. 4: Frontline Therapy for Renal Cell Carcinoma: Choosing the Right Regimen
Now Viewing
EP. 5: Treatment Strategies for Non-Clear Cell Renal Cell Carcinoma
EP. 6: Comparing Treatment Combinations in Renal Cell Carcinoma
EP. 7: Key Decision Factors in Selecting Frontline Therapy for Metastatic RCC
EP. 8: Sequencing and Second-Line Therapy in RCC: Patient Scenario
EP. 9: Managing AEs in Cabo Nivo Combination Therapy for Advanced RCC
EP. 10: Navigating Toxicity Discussions With Patients With Renal Cell Carcinoma
EP. 11: Novel Therapies for Advanced RCC: LITESPARK-005 and Treatment Sequencing
EP. 12: Triple Combination Therapies in RCC: Clinical Trial Insights
EP. 13: Key Takeaways: Advancements and Challenges in Kidney Cancer Treatment

Related Content:

Optimizing Therapy for Patients with Advanced Renal Cell CarcinomaOncLive Peer Exchange® Genitourinary Cancers
Kidney Cancer NCCN Guidelines Receive Major Updates, Prostate Cancer Adds Targeted Agents
Integrating HER3-DXd: Clinical Considerations for Future Approval and Implementation in Practice
Evaluating Response Rates in HERTHENA-Lung01: Insights on HER3-DXd